What is HC Wainwright's Forecast for Calumet Q3 Earnings?

Key Points

• HC Wainwright has significantly downgraded its earnings per share (EPS) estimates for Calumet, predicting a loss of $0.57 per share for Q3 2025, compared to an earlier forecast of $0.27.
• Calumet reported Q2 earnings of ($1.70) per share, falling short of analysts' consensus estimate of ($0.44), while the company’s revenue decreased by 9.4% year-over-year.
• Despite recent downgrades, analysts maintain a mixed outlook on Calumet, with a consensus rating of "Hold" and a varied target price range from $13.25 to $21.00.

Calumet, Inc. (NASDAQ:CLMT - Free Report) - HC Wainwright dropped their Q3 2025 earnings estimates for shares of Calumet in a report released on Monday, August 11th. HC Wainwright analyst A. Dayal now anticipates that the oil and gas company will post earnings of ($0.57) per share for the quarter, down from their previous estimate of ($0.27). The consensus estimate for Calumet's current full-year earnings is ($3.02) per share. HC Wainwright also issued estimates for Calumet's Q4 2025 earnings at ($0.58) EPS, FY2025 earnings at ($3.89) EPS, FY2026 earnings at ($1.49) EPS, FY2027 earnings at ($0.01) EPS and FY2028 earnings at $1.09 EPS.

Calumet (NASDAQ:CLMT - Get Free Report) last issued its earnings results on Friday, August 8th. The oil and gas company reported ($1.70) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.44) by ($1.26). The firm had revenue of $1.03 billion for the quarter, compared to analyst estimates of $982.88 million. The business's quarterly revenue was down 9.4% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.48) EPS.

Several other research analysts have also commented on CLMT. The Goldman Sachs Group dropped their price target on shares of Calumet from $16.00 to $14.00 and set a "buy" rating on the stock in a research note on Wednesday, April 30th. Bank of America began coverage on shares of Calumet in a research report on Tuesday, May 13th. They issued a "buy" rating and a $15.00 price objective for the company. Wells Fargo & Company dropped their price target on shares of Calumet from $23.00 to $21.00 and set an "overweight" rating for the company in a research note on Wednesday, May 14th. Finally, UBS Group set a $13.25 price objective on shares of Calumet and gave the company a "neutral" rating in a report on Tuesday, August 12th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $18.71.

Calumet Trading Down 1.1%

CLMT stock traded down $0.15 on Wednesday, hitting $13.60. 773,640 shares of the company's stock traded hands, compared to its average volume of 790,068. Calumet has a 1-year low of $7.68 and a 1-year high of $25.29. The stock has a market cap of $1.17 billion, a price-to-earnings ratio of -2.61 and a beta of 0.91. The stock has a fifty day moving average of $15.72 and a 200-day moving average of $13.91.

Insider Transactions at Calumet

In related news, Director Jennifer Straumins sold 100,000 shares of Calumet stock in a transaction on Monday, June 16th. The shares were sold at an average price of $16.23, for a total value of $1,623,000.00. Following the sale, the director owned 934,589 shares in the company, valued at $15,168,379.47. The trade was a 9.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Gregory J. Morical sold 25,123 shares of the business's stock in a transaction on Monday, June 16th. The shares were sold at an average price of $16.69, for a total transaction of $419,302.87. Following the sale, the senior vice president owned 39,415 shares in the company, valued at approximately $657,836.35. This trade represents a 38.93% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 275,123 shares of company stock worth $4,113,303. Insiders own 4.07% of the company's stock.

Hedge Funds Weigh In On Calumet

Hedge funds have recently bought and sold shares of the company. Police & Firemen s Retirement System of New Jersey purchased a new stake in Calumet during the 2nd quarter valued at approximately $245,000. Geode Capital Management LLC lifted its position in Calumet by 112.4% in the second quarter. Geode Capital Management LLC now owns 1,704,670 shares of the oil and gas company's stock worth $26,860,000 after buying an additional 901,933 shares during the last quarter. ProShare Advisors LLC bought a new stake in shares of Calumet during the second quarter worth $223,000. SP Asset Management LLC bought a new stake in shares of Calumet during the second quarter worth $205,000. Finally, Amalgamated Bank purchased a new position in shares of Calumet during the second quarter valued at $37,000. Institutional investors own 34.41% of the company's stock.

Calumet Company Profile

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.